SCHEMBL7733892

SCHEMBL7733892

CC(O)CCc1cc(Cl)cc2nc(-c3ccccc3Cl)oc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
TP53 P04637 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
C1R P00736 1/20 0.39
KDR P35968 2/20 0.38
ELANE P08246 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7735176 0.87 NPC1 (0.41) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL7725109 0.84 MAPT (0.44) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL7724920 0.82 NPC1 (0.42) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL7734118 0.82 HDAC3 (0.42) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL7733868 0.81 RXRA (0.46) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL8790418 0.80 MAPT (0.39) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL8790421 0.80 MAPT (0.39) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL7724412 0.78 NR4A2 (0.41) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL7724927 0.75 MTNR1A (0.44) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL2490307 0.75 ELANE (0.41) MAPTNPC1RAB9ATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372770-B1 TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF EURO-CELTIQUE, S.A. 2002-04-16 US disclosed
EP-0785927-A4 NOVEL BENZOXAZOLES EURO CELTIQUE SA (LU) 1997-12-29 EP disclosed
EP-0785927-A1 NOVEL BENZOXAZOLES Euroceltique S.A. (LU) 1997-07-30 EP disclosed
WO-1996011917-A1 NOVEL BENZOXAZOLES EURO-CELTIQUE, S.A. (LU) 1996-04-25 WO disclosed